Coldwater, MI, USA / WTVB | 1590 AM · 95.5 FM | The Voice of Branch County
Jan 23, 2021 11:59 AM
WASHINGTON (Reuters) - The United States is closely watching the more infectious variant of COVID-19 after British officials warned that it may also be more deadly, U.S. National Institutes of Health Director Francis Collins said on Saturday.
But U.S. health officials are somewhat more worried about a separate variant from South Africa, although that one has not yet been identified among U.S. cases of the novel coronavirus, he told MSNBC in an interview.
Collins noted the UK s data was preliminary, and said it was unclear why those with the UK variant faced a higher risk of death, whether by changes in the virus itself or other external causes such as pressures on the healthcare system.
WASHINGTON (REUTERS) - The United States is closely watching the more infectious variant of Covid-19 after British officials warned that it may also be more deadly, US National Institutes of Health director Francis Collins said on Saturday (Jan 23).
But US health officials are somewhat more worried about a separate variant from South Africa, although that one has not yet been identified among US cases of the novel coronavirus, he told MSNBC in an interview.
Collins noted that Britain s data was preliminary, and said it was unclear why those with the British variant faced a higher risk of death, whether by changes in the virus itself or other external causes such as pressures on the healthcare system.
Some large international studies found that moderately ill COVID-19 patients had significant benefit after receiving higher than usual doses of blood thinners.
The Latest: Psaki: Biden aims to avoid vaccine supply crunch berkshireeagle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from berkshireeagle.com Daily Mail and Mail on Sunday newspapers.
WASHINGTON New research finds full doses of blood thinners such as heparin can help moderately ill hospitalized COVID-19 patients avoid the need for breathing machines or other organ support.
The preliminary results come from three large, international studies testing various coronavirus treatments and haven’t yet been published. The U.S. National Institutes of Health and other sponsors released the results Friday to help doctors decide on appropriate care.
Nearly all hospitalized COVID-19 patients currently get low doses of a blood thinner to try to prevent clots from forming.
The new results show that “when we give higher doses of blood thinners to patients who are not already critically ill, there is a significant benefit in preventing them from getting sicker,” said Dr. Matthew Neal, a trauma surgeon at the University of Pittsburgh Medical Center and one study leader.